StockData

Acro Biomedical Co., Ltd. (ACBM) stock

ACBMOTCServices-Amusement & Recreation ServicesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.03+0.00 (0.00%)

Close on Oct 19, 2026Market cap $1.56MP/E –Yield –

Acro Biomedical r&d expenses

Research and development expenses are spending on new products and technology.

Acro Biomedical's R&D Expenses for the twelve months ending Dec 31, 2024 was $0, down 100.0% year over year. For fiscal 2024 it was $0, down 100.0% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2024Dec 31, 2024$0-100.0%
FY2023Dec 31, 2023$4.79M-52.4%
FY2022Dec 31, 2022$10.08M+90.7%
FY2021Dec 31, 2021$5.29M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2024CQ4 2024Dec 31, 2024$0–
Q3 FY2024CQ3 2024Sep 30, 2024$0-100.0%
Q2 FY2024CQ2 2024Jun 30, 2024$0-100.0%
Q1 FY2024CQ1 2024Mar 31, 2024$0-100.0%
Q4 FY2023CQ4 2023Dec 31, 2023$0-100.0%
Q3 FY2023CQ3 2023Sep 30, 2023$396.55K-84.3%
Q2 FY2023CQ2 2023Jun 30, 2023$1.88M-25.5%
Q1 FY2023CQ1 2023Mar 31, 2023$2.52M0.0%
Q4 FY2022CQ4 2022Dec 31, 2022$2.52M0.0%
Q3 FY2022CQ3 2022Sep 30, 2022$2.52M+18.7%
Q2 FY2022CQ2 2022Jun 30, 2022$2.52M+292.7%
Q1 FY2022CQ1 2022Mar 31, 2022$2.52M–
Q4 FY2021CQ4 2021Dec 31, 2021$2.52M–
Q3 FY2021CQ3 2021Sep 30, 2021$2.12M–
Q2 FY2021CQ2 2021Jun 30, 2021$641.73K–

More Acro Biomedical figures

See a number that looks wrong?